Drug Shortage Report for ACETYLCYSTEINE SOLUTION USP
Report ID | 172409 |
Drug Identification Number | 02459906 |
Brand name | ACETYLCYSTEINE SOLUTION USP |
Common or Proper name | ACETYLCYSTEINE SOLUTION USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLCYSTEINE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION |
Packaging size | 10ML |
ATC code | R05CB |
ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-11-30 |
Actual start date | 2022-11-03 |
Estimated end date | 2023-06-09 |
Actual end date | 2022-06-14 |
Shortage status | Avoided shortage |
Updated date | 2023-06-14 |
Company comments | Inventory available in 30mL vial format - Hikma product code 0015AI02. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-10-21 | English | Compare |
v2 | 2022-10-21 | French | Compare |
v3 | 2022-11-03 | English | Compare |
v4 | 2022-11-03 | English | Compare |
v5 | 2022-11-03 | French | Compare |
v6 | 2022-11-04 | English | Compare |
v7 | 2022-11-18 | English | Compare |
v8 | 2023-02-02 | English | Compare |
v9 | 2023-02-02 | French | Compare |
v10 | 2023-03-08 | English | Compare |
v11 | 2023-03-08 | French | Compare |
v12 | 2023-05-01 | English | Compare |
v13 | 2023-05-01 | French | Compare |
v14 | 2023-05-19 | English | Compare |
v15 | 2023-05-19 | French | Compare |
v16 | 2023-06-02 | English | Compare |
v17 | 2023-06-05 | English | Compare |
v18 | 2023-06-05 | French | Compare |
v19 | 2023-06-14 | English | Compare |
v20 | 2023-06-14 | French | Compare |
Showing 1 to 20 of 20